BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29857568)

  • 1. Botulinum Toxin for Central Neuropathic Pain.
    Park J; Chung ME
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29857568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin for the Treatment of Neuropathic Pain.
    Park J; Park HJ
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
    Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
    Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical review of the use of Botulinum Toxin type A in managing central neuropathic pain in patients with spinal cord injury.
    Lakra C; Cohen H
    J Spinal Cord Med; 2022 Sep; 45(5):651-655. PubMed ID: 33263489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for neuropathic pain and spasticity: an overview.
    Brown EA; Schütz SG; Simpson DM
    Pain Manag; 2014 Mar; 4(2):129-51. PubMed ID: 24641437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia.
    Liu HT; Tsai SK; Kao MC; Hu JS
    Pain Med; 2006; 7(1):89-91. PubMed ID: 16533208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review.
    Dekhne A; Goklani HD; Doshi N; Baskara Salian R; Gandhi SK; Patel P
    Cureus; 2023 Oct; 15(10):e46848. PubMed ID: 37954779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A focused review on the use of botulinum toxins for neuropathic pain.
    Argoff CE
    Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury.
    Han ZA; Song DH; Oh HM; Chung ME
    Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin for pain management: insights from animal models.
    Pavone F; Luvisetto S
    Toxins (Basel); 2010 Dec; 2(12):2890-913. PubMed ID: 22069581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature.
    Jeynes LC; Gauci CA
    Pain Pract; 2008; 8(4):269-76. PubMed ID: 18503628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.
    Lunde HM; Torkildsen Ø; Bø L; Bertelsen AK
    Headache; 2016 Jun; 56(6):1035-9. PubMed ID: 26992044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review.
    Val M; Delcanho R; Ferrari M; Guarda Nardini L; Manfredini D
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin A and neuropathic pain: An update.
    Spagna A; Attal N
    Toxicon; 2023 Aug; 232():107208. PubMed ID: 37385479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin in the Field of Dermatology: Novel Indications.
    Kim YS; Hong ES; Kim HS
    Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29258169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
    Ranoux D
    Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models.
    Ma L; Nagai J; Sekino Y; Goto Y; Nakahira S; Ueda H
    J Pharmacol Sci; 2012; 119(3):282-6. PubMed ID: 22785019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type B: a new injectable treatment for cervical dystonia.
    Brashear A
    Expert Opin Investig Drugs; 2001 Dec; 10(12):2191-9. PubMed ID: 11772315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.